Lu-177 DOTA-ABM-5G
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lu-177 DOTA-ABM-5G, covering 2025-05-28 to 2025-05-28. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer [EARLY_Phase 1]